vs
Side-by-side financial comparison of FRANKLIN STREET PROPERTIES CORP (FSP) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $26.0M, roughly 1.2× FRANKLIN STREET PROPERTIES CORP). FRANKLIN STREET PROPERTIES CORP runs the higher net margin — -28.1% vs -32.1%, a 4.0% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -8.2%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-12.7M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -8.7%).
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
FSP vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $31.1M |
| Net Profit | $-7.3M | $-10.0M |
| Gross Margin | 59.4% | 25.0% |
| Operating Margin | -27.9% | -9.9% |
| Net Margin | -28.1% | -32.1% |
| Revenue YoY | -8.2% | -4.5% |
| Net Profit YoY | 14.1% | -52.0% |
| EPS (diluted) | $-0.06 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | — | ||
| Q3 25 | $27.3M | $31.1M | ||
| Q2 25 | $26.7M | — | ||
| Q1 25 | $27.1M | $35.2M | ||
| Q4 24 | $28.4M | $32.6M | ||
| Q3 24 | $29.7M | $24.7M | ||
| Q2 24 | $30.8M | — | ||
| Q1 24 | $31.2M | $35.7M |
| Q4 25 | $-7.3M | — | ||
| Q3 25 | $-8.3M | $-10.0M | ||
| Q2 25 | $-7.9M | — | ||
| Q1 25 | $-21.4M | $-14.8M | ||
| Q4 24 | $-8.5M | $-6.6M | ||
| Q3 24 | $-15.6M | $-16.2M | ||
| Q2 24 | $-21.0M | — | ||
| Q1 24 | $-7.6M | $15.6M |
| Q4 25 | 59.4% | — | ||
| Q3 25 | 60.9% | 25.0% | ||
| Q2 25 | 59.9% | — | ||
| Q1 25 | 62.8% | 28.0% | ||
| Q4 24 | 59.7% | 34.0% | ||
| Q3 24 | 61.0% | 21.8% | ||
| Q2 24 | 64.2% | — | ||
| Q1 24 | 64.7% | 33.3% |
| Q4 25 | -27.9% | — | ||
| Q3 25 | -30.5% | -9.9% | ||
| Q2 25 | -29.2% | — | ||
| Q1 25 | -78.9% | -25.7% | ||
| Q4 24 | -29.9% | -6.0% | ||
| Q3 24 | -52.4% | -46.9% | ||
| Q2 24 | -68.0% | — | ||
| Q1 24 | -24.0% | -2.5% |
| Q4 25 | -28.1% | — | ||
| Q3 25 | -30.5% | -32.1% | ||
| Q2 25 | -29.5% | — | ||
| Q1 25 | -79.1% | -42.0% | ||
| Q4 24 | -30.0% | -20.2% | ||
| Q3 24 | -52.6% | -65.7% | ||
| Q2 24 | -68.2% | — | ||
| Q1 24 | -24.2% | 43.8% |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $-0.08 | $-0.29 | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.21 | $-0.47 | ||
| Q4 24 | $-0.09 | $-0.25 | ||
| Q3 24 | $-0.15 | $-0.53 | ||
| Q2 24 | $-0.20 | — | ||
| Q1 24 | $-0.07 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.6M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $607.0M | $-10.5M |
| Total Assets | $892.9M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.6M | — | ||
| Q3 25 | $31.4M | $18.9M | ||
| Q2 25 | $29.4M | — | ||
| Q1 25 | $30.2M | $5.4M | ||
| Q4 24 | $41.1M | $9.5M | ||
| Q3 24 | $40.9M | — | ||
| Q2 24 | $30.2M | — | ||
| Q1 24 | $34.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $607.0M | — | ||
| Q3 25 | $615.3M | $-10.5M | ||
| Q2 25 | $624.7M | — | ||
| Q1 25 | $633.4M | $2.2M | ||
| Q4 24 | $655.9M | $15.4M | ||
| Q3 24 | $665.4M | $-3.9M | ||
| Q2 24 | $682.1M | — | ||
| Q1 24 | $703.9M | $17.7M |
| Q4 25 | $892.9M | — | ||
| Q3 25 | $901.0M | $235.2M | ||
| Q2 25 | $903.2M | — | ||
| Q1 25 | $916.4M | $237.7M | ||
| Q4 24 | $946.9M | $255.4M | ||
| Q3 24 | $981.5M | $246.8M | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.0B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.8M | $1.8M |
| Free Cash FlowOCF − Capex | $-12.7M | $25.0K |
| FCF MarginFCF / Revenue | -48.6% | 0.1% |
| Capex IntensityCapex / Revenue | 63.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.3M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | — | ||
| Q3 25 | $8.3M | $1.8M | ||
| Q2 25 | $-2.9M | — | ||
| Q1 25 | $-5.5M | $1.2M | ||
| Q4 24 | $9.0M | $-6.1M | ||
| Q3 24 | $14.5M | $-613.0K | ||
| Q2 24 | $-648.0K | — | ||
| Q1 24 | $-7.1M | $-1.4M |
| Q4 25 | $-12.7M | — | ||
| Q3 25 | $3.0M | $25.0K | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-9.9M | $-4.3M | ||
| Q4 24 | $-16.2M | $-8.6M | ||
| Q3 24 | $8.6M | $-4.0M | ||
| Q2 24 | $-5.1M | — | ||
| Q1 24 | $-15.8M | $-7.8M |
| Q4 25 | -48.6% | — | ||
| Q3 25 | 11.0% | 0.1% | ||
| Q2 25 | -21.5% | — | ||
| Q1 25 | -36.7% | -12.1% | ||
| Q4 24 | -57.2% | -26.3% | ||
| Q3 24 | 29.1% | -16.3% | ||
| Q2 24 | -16.7% | — | ||
| Q1 24 | -50.8% | -21.8% |
| Q4 25 | 63.0% | — | ||
| Q3 25 | 19.4% | 5.6% | ||
| Q2 25 | 10.7% | — | ||
| Q1 25 | 16.4% | 15.5% | ||
| Q4 24 | 88.9% | 7.5% | ||
| Q3 24 | 19.6% | 13.9% | ||
| Q2 24 | 14.6% | — | ||
| Q1 24 | 28.1% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSP
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
